Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

Clinical trial NCT06406114 · RECRUITING

Trial details

NCT number: NCT06406114
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Drug Allergy Cephalosporin Allergy Drug Hypersensitivity Antibiotic Allergy Beta Lactam Adverse Reaction Drug-Induced Anaphylaxis Cephalosporin Reaction

Start date: 2025-05-05
Primary completion: 2028-07-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.